Autor: "Halligan RK" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Understanding the role of SGLT2 inhibitors in glycogen storage disease type Ib: the experience of one UK centre.
Autorzy:: Halligan RK; Inherited Metabolic Diseases, Evelina London Children's Hospital, London, SE1 7EH, UK. r.halligan@nhs.net.
Dalton RN; WellChild Laboratory, Evelina London Children's Hospital, London, UK.
Turner C; WellChild Laboratory, Evelina London Children's Hospital, London, UK.
Lewis KA; Inherited Metabolic Diseases, Evelina London Children's Hospital, London, SE1 7EH, UK.
Mundy HR; Inherited Metabolic Diseases, Evelina London Children's Hospital, London, SE1 7EH, UK.; Pokaż więcej
Źródło:: Orphanet journal of rare diseases [Orphanet J Rare Dis] 2022 May 12; Vol. 17 (1), pp. 195. Date of Electronic Publication: 2022 May 12.
Typ publikacji:: Journal Article
MeSH Terms:: Glycogen Storage Disease Type I*/complications
Glycogen Storage Disease Type I*/drug therapy
Hypoglycemia*/drug therapy
Neutropenia*
Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use
Adult ; Antiporters ; Child ; Humans ; Monosaccharide Transport Proteins ; United Kingdom
SCR Disease Name:: Glycogen Storage Disease IB

Czasopismo naukowe

Informacja